MTD vs ORKA · P/E 27, rev $1.97B vs $4.27B cap
Mettler-Toledo International Inc (MTD) versus Oruka Therapeutics, Inc. (ORKA) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
ORKA does not have a complete income-statement cache yet.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. ORKA currently screens at market cap $4.27B.
Not investment advice. Open the MTD and ORKA stock pages for the full models.
Not investment advice.